KPIs & Operating Metrics(New)
Breakdown Of AssetsCost Of SalesEmployee StatisticsGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome Before Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total Revenue %OPEX SegregationProperty, Plant And Equipment BreakdownRevenue By Business SegmentRevenue By Business Segment %Revenue By Business Segment AnnualRevenue By Business Segment Annual %Revenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By Product BiosimilarsRevenue By Product (Biosimilars) AnnualRevenue By Product CardiovascularRevenue By Product (Cardiovascular) AnnualRevenue By Product Non Opid Pain , Bone & DermatologyRevenue By Product (Non Opid Pain , Bone & Dermatology) AnnualRevenue By Product RespiratoryRevenue By Product (Respiratory) AnnualRevenue By Product Women'S HealthRevenue By Product (Women'S Health) Annual
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Gross Profit (2020 - 2025)

Historic Gross Profit for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $857.0 million.

  • Organon's Gross Profit fell 715.06% to $857.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year decrease of 712.37%. This contributed to the annual value of $3.7 billion for FY2024, which is 88.05% down from last year.
  • Latest data reveals that Organon reported Gross Profit of $857.0 million as of Q3 2025, which was down 715.06% from $874.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Gross Profit ranged from a high of $1.0 billion in Q2 2021 and a low of $841.0 million during Q1 2025
  • For the 5-year period, Organon's Gross Profit averaged around $938.8 million, with its median value being $939.0 million (2024).
  • Its Gross Profit has fluctuated over the past 5 years, first plummeted by 2632.85% in 2021, then soared by 994.54% in 2022.
  • Organon's Gross Profit (Quarter) stood at $1.0 billion in 2021, then dropped by 11.25% to $891.0 million in 2022, then grew by 2.69% to $915.0 million in 2023, then dropped by 2.08% to $896.0 million in 2024, then dropped by 4.35% to $857.0 million in 2025.
  • Its last three reported values are $857.0 million in Q3 2025, $874.0 million for Q2 2025, and $841.0 million during Q1 2025.